Keros Therapeutics Inc (KROS) — Cash Flow Reinvestment Rate
Keros Therapeutics Inc (KROS) has a Cash Flow Reinvestment Rate of 0.08x as of September 2025, reinvesting $264.00K (capex $132.00K plus investments $-132.00K) from operating cash flow of $3.25 Million. Explore KROS capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Keros Therapeutics Inc Cash Flow Reinvestment Rate (2018–2018)
Historical reinvestment intensity for Keros Therapeutics Inc across 1 annual periods. Also explore how large is Keros Therapeutics Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Keros Therapeutics Inc (2018–2018)
Year-by-year capital reinvestment analysis for Keros Therapeutics Inc. For live market cap and broader valuation context, see KROS stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.06x | $434.00K | $7.04 Million | $217.00K | — |